MedPath

This study compares two drugs namely 0.5percent bupivacaine and 0.75 percent ropivacaine with an additive of dexmedetomidine used in transversus abdominis plane block for the duration of postoperative pain relief in patients undergoing lower abdominal surgeries under general anaesthesia

Phase 3
Conditions
Health Condition 1: G891- Acute pain, not elsewhere classifiedHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2024/07/070018
Lead Sponsor
Dr Harshitha Konanki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients between ages of 18 and 65 years, ASA grade 1 and 2 undergoing lower abdominal surgeries under General Anaesthesia

Exclusion Criteria

ASA grade 3 and 4

Hypersensitivity to Local anaesthesia

patients with infection at the site of injection

patients who have coagulopathies

patients on systemic anticoagulant medications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of postoperative analgesia after Transversus Abdominis Plane block in patients undergoing abdominal surgeries using 0.5 percent bupivacaine and dexmedetomidine compared with 0.75 percent ropivacaine and dexmedetomidineTimepoint: 2 hours, 4 hours, 9 hours, 18 hours, 24 hours
Secondary Outcome Measures
NameTimeMethod
Assessment of the effect of Transversus Abdominis Plane block on Perioperative hemodynamic status- Heart rate, Non-invasive Blood Pressure, SpO2Timepoint: 2 hours, 4 hours, 9 hours, 18 hours, 24 hours
© Copyright 2025. All Rights Reserved by MedPath